GlucoSet

About

GlucoSet AS is a Norwegian medical device company developing a glucose monitoring sensor for intensive care unit (ICU) patients. Founded in December 2011, the company has 13 employees.

Technology

GlucoSet's sensor is designed to solve a specific clinical problem: accurate glucose monitoring in critically ill ICU patients. The technology:

• Is minimally invasive - accesses through an indwelling arterial catheter without disrupting its current use
• Requires no new catheters - leverages existing arterial access
• Displaces no other equipment - integrates with existing ICU setup
• Is less susceptible to interferences - the arterial access approach may improve measurement reliability compared to subcutaneous sensors

Clinical Need

Glucose control in ICU patients is a significant challenge:

• Both hyperglycemia and hypoglycemia in critically ill patients are associated with increased mortality
• Current glucose monitoring methods (point-of-care, subcutaneous continuous glucose monitoring) have limitations in the ICU setting
• Tight glycemic control in ICUs has been shown to improve outcomes but is difficult to achieve safely

Market Position

GlucoSet targets the ICU glucose monitoring market with a solution designed specifically for the constraints of critical care environments. The company describes the problem as "unsolved," indicating an unmet need.